SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001192482-14-000195
Filing Date
2014-10-07
Accepted
2014-10-07 16:01:22
Documents
1
Period of Report
2014-10-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2838
  Complete submission text file 0001192482-14-000195.txt   4496
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Issuer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FIBROCELL SCIENCE, INC. 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address
Smith Kimberly M. (Reporting) CIK: 0001621445 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31564 | Film No.: 141145650